Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Symposium on nanomedicine to introduce new nanotech facility office at WCMC

Abstract:
To bring Cornell's medical researchers closer to cutting-edge nanotechnology techniques and to help forge intercampus research collaborations, the Cornell NanoScale Science and Technology Facility (CNF) has opened a branch at New York's Weill Cornell Medical College (WCMC).

Symposium on nanomedicine to introduce new nanotech facility office at WCMC

ITHACA, NY | Posted on September 13th, 2008

The opening of the office will be marked by a nanomedicine symposium, Sept. 24 from 2 to 5:30 p.m. at WCMC. The event will introduce CNF and its staff, showcase microscale and nanoscale technologies, and promote research collaborations between the Ithaca and New York City campuses.

"We are responding to a trend we see in our user base; namely, an increasing number of people taking advantage of nano and microfabrication techniques for clinical and basic life sciences research," said George Malliaras, the Lester B. Knight Director of CNF.

The symposium will include remarks by Malliaras, speakers and a poster presentation. Keynote speakers will be Michael Shuler, Cornell's Samuel B. Eckert Professor of Chemical Engineering, and Lance Kam, assistant professor of biomedical engineering at Columbia University.

CNF is one of the nation's premier nanofabrication facilities, supporting a broad range of nanoscale science and technology projects with state-of-the-art equipment, resources and expert staff. Housed in Duffield Hall on Cornell's Ithaca campus and open 24 hours a day, the facility boasts more than 700 users doing nanofabrication, synthesis, computation and characterization of nanoscale devices and systems.

Preregistration for the event is not necessary.

####

For more information, please click here

Contacts:
Cornell Chronicle:
Anne Ju
(607) 255-9735


Media Contact:
Blaine Friedlander
(607) 254-8093

Copyright © Cornell University

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Searching for errors in the quantum world September 21st, 2018

Viral RNA sensing: Optical detection of picomolar concentrations of RNA using switches in plasmonic chirality September 21st, 2018

UT engineers develop first method for controlling nanomotors: Breakthrough for nanotechnology as UT engineers develop first method for switching the mechanical motion of nanomotors September 21st, 2018

Nanobiotix: Update on Head and Neck Phase I/II Trial with NBTXR3 and Other program data presented at ImmunoRad 2018 September 20th, 2018

Nanomedicine

Viral RNA sensing: Optical detection of picomolar concentrations of RNA using switches in plasmonic chirality September 21st, 2018

UT engineers develop first method for controlling nanomotors: Breakthrough for nanotechnology as UT engineers develop first method for switching the mechanical motion of nanomotors September 21st, 2018

Nanobiotix: Update on Head and Neck Phase I/II Trial with NBTXR3 and Other program data presented at ImmunoRad 2018 September 20th, 2018

NUS researchers invent new test kit for quick, accurate and low-cost screening of diseases: Test results are denoted by a color change and could be further analyzed by a smartphone app, making it attractive as a point-of-care diagnostic device September 19th, 2018

Announcements

Searching for errors in the quantum world September 21st, 2018

Viral RNA sensing: Optical detection of picomolar concentrations of RNA using switches in plasmonic chirality September 21st, 2018

UT engineers develop first method for controlling nanomotors: Breakthrough for nanotechnology as UT engineers develop first method for switching the mechanical motion of nanomotors September 21st, 2018

Nanobiotix: Update on Head and Neck Phase I/II Trial with NBTXR3 and Other program data presented at ImmunoRad 2018 September 20th, 2018

Events/Classes

Nanobiotix: Update on Head and Neck Phase I/II Trial with NBTXR3 and Other program data presented at ImmunoRad 2018 September 20th, 2018

Arrowhead Pharmaceuticals to Present at Upcoming September 2018 Conferences August 31st, 2018

Stress-free ALD from Picosun August 28th, 2018

Kavli Lectures: New vision of nanomaterial synthesis and light-fueled space travel August 8th, 2018

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project